Ionis Pharmaceuticals (IONS) Receivables - Other (2016 - 2025)
Historic Receivables - Other for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to $24.6 million.
- Ionis Pharmaceuticals' Receivables - Other rose 3726.02% to $24.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.6 million, marking a year-over-year increase of 3726.02%. This contributed to the annual value of $92.2 million for FY2024, which is 571.7% down from last year.
- As of Q3 2025, Ionis Pharmaceuticals' Receivables - Other stood at $24.6 million, which was up 3726.02% from $52.6 million recorded in Q2 2025.
- Ionis Pharmaceuticals' Receivables - Other's 5-year high stood at $142.4 million during Q3 2023, with a 5-year trough of $5.1 million in Q1 2024.
- In the last 5 years, Ionis Pharmaceuticals' Receivables - Other had a median value of $25.5 million in 2022 and averaged $38.1 million.
- As far as peak fluctuations go, Ionis Pharmaceuticals' Receivables - Other skyrocketed by 204234.76% in 2023, and later tumbled by 8740.65% in 2024.
- Ionis Pharmaceuticals' Receivables - Other (Quarter) stood at $61.9 million in 2021, then crashed by 58.74% to $25.5 million in 2022, then surged by 282.87% to $97.8 million in 2023, then dropped by 5.72% to $92.2 million in 2024, then plummeted by 73.31% to $24.6 million in 2025.
- Its Receivables - Other stands at $24.6 million for Q3 2025, versus $52.6 million for Q2 2025 and $39.7 million for Q1 2025.